David Laharie

41PUBLICATIONS
66CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Rheumatology and arthritisMedical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)Immunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (41)

|Sep 12, 2026
Acceptability and tolerability of risankizumab maintenance therapy administered via on-body injector in patients with Crohn's disease: Results of the ACCEPT-OBI study.

|Jul 24, 2026
Ustekinumab for fistulising perianal Crohn's disease: a randomised placebo-controlled trial from the GETAID.

|May 09, 2026
Effect of Mirikizumab on Clinical and Endoscopic Outcomes Based on Prior Advanced Therapy Failure in Patients With Moderately to Severely Active Ulcerative Colitis.

|May 01, 2026
The GETAID: over 40 years of academic research in IBD.

|Apr 27, 2026
One-Year Effectiveness of Upadacitinib in Perianal Crohn's Disease: A Real-World GETAID Study.

|Apr 20, 2026
Patterns of conventional therapy use and advanced therapy initiation drivers in inflammatory bowel disease.

Pageof 7

Frequent Collaborators

15 joint publications

Laurent Peyrin-Biroulet

12 joint publications

Guillaume Bouguen

11 joint publications

Aurelien Amiot

9 joint publications

Mathurin Fumery